Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Marc Gauthier"'
Autor:
Jean-Marc Gauthier
Publikováno v:
Proceedings of the SIGGRAPH Asia 2022 Real-Time Live!.
Publikováno v:
Curr Opin Immunol
Asthma as a clinical entity manifests with a broad spectrum of disease severity. Unlike milder asthma, severe disease is poorly controlled by inhaled corticosteroids, the current standard of care. Transcriptomic data, along with patient characteristi
Autor:
Marc Gauthier, Sagar Laxman Kale, Timothy B. Oriss, Michael Gorry, Richard P. Ramonell, Kathryn Dalton, Prabir Ray, John V. Fahy, Max A. Seibold, Mario Castro, Nizar Jarjour, Benjamin Gaston, Eugene R. Bleecker, Deborah A. Meyers, Wendy Moore, Annette T. Hastie, Elliot Israel, Bruce D. Levy, David Mauger, Serpil Erzurum, Suzy A. Comhair, Sally E. Wenzel, Anuradha Ray
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB224
Publikováno v:
Web of Science
Autor:
Ian J. Barbash, Marc Gauthier, Jason D. Christie, Keven M. Robinson, Faraaz Ali Shah, Alison Morris, Divay Chandra, Corrine R. Kliment, Katherine R. Courtright, Leslie P. Scheunemann, Jacob S. Brenner
Publikováno v:
ATS Scholar
The coronavirus disease (COVID-19) pandemic has created significant stressors for the academic and scientific community, with unique challenges for early-career physician-scientists. The pandemic-related disruptions have significantly affected resear
Publikováno v:
Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology
Background More than 300 million people carry a diagnosis of asthma, with data to suggest that they are at a higher risk for infection or adverse outcomes from severe acute respiratory syndrome coronavirus 2. Asthma is remarkably heterogeneous, and i
Publikováno v:
D31. ASTHMA EPIDEMIOLOGY.
Autor:
Sagar Laxman Kale, Sally E. Wenzel, Anuradha Ray, Kathryn Scholl, Marc Gauthier, T.B. Oriss, Prabir Ray
Publikováno v:
A21. AIRWAY IMMUNOLOGY.
Publikováno v:
Physiol Rev
While the term asthma has long been known to describe heterogeneous groupings of patients, only recently have data evolved which enable a molecular understanding of the clinical differences. The evolution of transcriptomics (and other ‘omics platfo